Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.39
Delayed Data
As of Mar 27
 -0.005 / -0.36%
Today’s Change
1.19
Today|||52-Week Range
2.09
-0.36%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Peregrine Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +188.81% increase from the last price of 1.39.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Peregrine Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$6.4M
Reporting Date
Jul 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.16%
 
 
 
 
 
 
Growthannually -36.36%
 
 
 
 
 
 

Sales

Growthquarterly 13.08%
 
 
 
 
 
 
Growthannually 6.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account